News|Articles|November 5, 2025
Outsourcing Small Molecule Purification Processes
Key Takeaways
- Outsourcing medium-complexity tasks enabled scientists to focus on core research, enhancing innovation and strategic drug development efforts.
- Tasks such as cell line maintenance, QC assays, and routine chromatography were outsourced to improve overall efficiency.
A leading global pharmaceutical company needed to find new ways to help scientists focus more time and attention on innovation and strategic drug projects. Medium-complexity tasks, such as maintaining cell lines, performing QC assays, and conducting routine chromatography work, were outsourced, allowing scientists to focus on their core research while improving overall efficiency.
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Experts Probe CNPV Impacts: Part II
2
CDC’s Policy Shift on Autism and Vaccines Spurs Biopharma Quality/System Concerns
3
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
4
Ask the Expert: Audits, Inspections, and CDMOs
5
